Data / Form D filings / Research Discovery Innovation Inc.
Research Discovery Innovation Inc.: Form D filing
Research Discovery Innovation Inc., a pharmaceuticals company in Chicago, IL, filed a Form D with the SEC in 2026. The latest, on July 29, 2026, reports $39 sold of a $39 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 875 N MICHIGAN AVENUE SUITE 3950, Chicago, IL, 60611
- Phone
- (312) 787-8780
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2147879
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | New notice | $39 | $39 | 1 | Jul 20, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bo von Barnekow-Lofberg | Executive Officer, Director | |
| Stig Lofberg | Executive Officer | |
| Christina Lofberg-Kaij | Executive Officer |
Every Form D from the week of Jul 27, 2026 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Research Discovery Innovation Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.